FDA Grants Approval for Gadobutrol ANDA219146 by Zenara
The FDA has granted approval for the ANDA219146 application for Gadobutrol submitted by Zenara.
Asset / Drug
Drug and asset intelligence for Zenara with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.